After being diagnosed with MS, it's common to feel a new urgency around food. With so much online messaging claiming certain diets can heal or dramatically change MS, those promises can be hard to tune out — especially when you're trying to make sense of a diagnosis that upended everything.

That reaction makes sense. Food isn't trivial in our lives.

"Perhaps the most intimate relationship each of us will ever have is not with any fellow member of our own human species. Instead, it is between our bodies and our food." — Scientific American, September 2013

To suggest that fuel is the only role food plays in our lives is akin to saying that sex is only for reproduction. Of course, you turned to food first. It represents something tangible you can influence right now, while so much about MS remains unpredictable.

If you're living with MS, "diet" probably immediately calls up the Wahls Protocol, Swank, anti-inflammatory eating, cutting gluten or dairy — whatever you've read most recently. It all feels practical and within reach. MS is the diagnosis that changed everything. It's what you research, what your neurologist monitors, and what shapes how you think about your health. So, of course, you see food through that lens.

But here's what doesn't get said often enough: for most people with MS, the dietary changes most likely to affect long-term outcomes — disability progression, relapse risk, quality of life — aren't MS-specific diets. They're evidence-based interventions that address other common health conditions linked to worse MS outcomes.

That's what the research shows. And once you see it, it shifts how you think about food, health, and MS.

Quick Takeaways

• About two-thirds of people with MS have at least one other chronic condition. These comorbidities are consistently linked to faster disability progression, higher relapse rates, and worse neurological outcomes.

• The dietary changes most likely to affect long-term MS outcomes aren't MS-specific diets — they're evidence-based interventions for hypertension, high cholesterol, diabetes, and other conditions linked to worse MS progression.

• Diagnostic overshadowing — when MS dominates all health decisions — means comorbidities often go under-managed, including through diet.

• Some popular MS diets may conflict with evidence-based management of common comorbidities. Your nutrition plan should account for your full health picture.

• You don't need a branded MS diet. You need a plan that targets what's actually measurable and modifiable in your specific situation.

Table of Contents

How Common Are Comorbidities in MS?

More common than most people think.

Large international studies show about two-thirds of people with MS have at least one other chronic condition — meaning MS alone is less common than MS plus something else (Marck et al., 2016; Maric et al., 2021).

The most common ones include depression and anxiety, high blood pressure, obesity, diabetes or insulin resistance, cardiovascular disease, and abnormal cholesterol levels.

So statistically, if you're living with MS, there's a good chance you're also managing at least one of these — whether you label it that way or not.

And these aren't side notes in your medical chart. Research consistently links them to faster disability progression, higher relapse risk, and worse long-term neurological outcomes.

Which raises a question worth sitting with: if two-thirds of us have at least one other chronic condition, and those conditions are independently making MS worse, why does nearly all the MS diet conversation focus on MS alone?

Why Other Health Conditions Get Overlooked in MS Care

There's a phenomenon called diagnostic overshadowing — when one major diagnosis becomes so central that other conditions receive less attention. When MS becomes the lens through which every health decision is filtered, hypertension, cholesterol, diabetes, depression, or obesity can quietly go under-managed. Not from carelessness. Because the spotlight is elsewhere.

The Diagnosis Takes Up All the Space

MS takes up space — cognitively, emotionally, practically. I know this firsthand. Whether you're newly diagnosed or years into living with the disease, it can become the organizing framework for how you think about your health.

The questions become: What should I eat for MS? What supplements help MS? What diet slows MS progression?

Meanwhile, blood pressure, cholesterol, and blood glucose feel secondary — even though each directly influences long-term neurological outcomes in MS. I've worked with people who could outline the specific demands of every MS diet protocol they'd tried but didn't know their own blood pressure or cholesterol numbers. That's not a personal failing. That's diagnostic overshadowing, doing exactly what it does.

The Healthcare System Doesn't Connect the Dots

Care fragmentation makes this worse. A primary care provider might diagnose high blood pressure or insulin resistance but feel unsure about how nutrition fits into MS care — and send food-related questions to the MS care team. Neurologists, understandably focused on your neurological care, may not be equipped to provide nuanced nutrition guidance and may assume cardiometabolic risks are being handled in primary care. A registered dietitian, if one is even involved, may not have specific training in MS.

Despite everyone's best efforts, nutrition slips through the gaps.

There's a research-level version of this problem, too. Scientists studying diet in MS and researchers focused on managing comorbidities often operate in separate worlds. Both groups produce rigorous evidence, but their findings rarely get woven together. So, a very practical question — How should someone with MS and hypertension actually eat? — doesn't neatly belong to either camp. That translation usually has to happen in the clinic, in real time, and only if someone thinks to ask the right question.

Diagnostic Overshadowing Starts Before MS Is Even Diagnosed

The effects don't begin after diagnosis. They often begin before it. Research shows that existing health conditions can delay an MS diagnosis itself. Cerebrovascular disease has been shown to more than double the odds of diagnostic delay, and conditions including vascular, autoimmune, musculoskeletal, and mental health disorders are also linked to longer times to diagnosis (Marrie et al., 2009; Thormann et al., 2017).

People whose MS diagnosis was postponed because symptoms were attributed to other conditions were more disabled by the time MS was finally identified. The cost of overshadowing had already accumulated.

Once MS is diagnosed, the pattern continues. Someone with MS and high blood pressure might spend months experimenting with diets promoted for MS, without clear guidance on how those choices affect their hypertension. Someone with MS and high cholesterol may adopt an MS-branded diet that's higher in saturated fat, not realizing it could worsen cardiovascular risk. Someone with MS and insulin resistance might follow a restrictive elimination plan, while blood glucose management doesn't receive focused attention.

The conditions most strongly linked to worse MS outcomes may receive the least dietary attention.

How Comorbidities Affect MS Progression — What the Research Shows

When researchers study progression, relapse risk, disability milestones, MRI changes, quality of life, and mortality, one pattern keeps showing up: comorbidities matter. A lot.

Let's apply the problem → intervention → outcome framework here. The problem is clear: comorbidities are common in MS and consistently linked to worse outcomes. The question is whether managing them — including through diet — changes the trajectory. Here's what the research says.

More Comorbidities = Higher Disease Activity

A 2024 analysis (Salter et al.) found that having three or more comorbidities increased the risk of MS disease activity by 14%. Having two or more cardiometabolic conditions — such as hypertension, diabetes, high cholesterol, or obesity — increased disease activity risk by 21%.

Disease activity here includes new relapses, disability worsening, and new MRI lesions. That's a measurable shift in disease trajectory.

By comparison, clinical trials of MS-specific diets have not demonstrated disease modification of this magnitude. That's not a knock on eating well. It's a calibration of where the evidence is strongest.

Each Additional Condition Worsens the Disability Trajectory

The pattern is straightforward: the more physical comorbidities someone has, the worse the disability trajectory tends to be.

Each additional physical comorbidity increases the odds of moderate disability by 13% and severe disability by 18% (Marrie et al., 2009). Each added condition is also associated with a measurable increase in EDSS disability scores (Zhang et al., 2018).

Vascular Health and Mobility

The vascular data are especially striking. People with MS who also have vascular conditions — like high blood pressure, diabetes, or high cholesterol — tend to need walking assistance about six years earlier (Culpepper et al., 2015).

Six years of walking independence. Potentially shortened by conditions we already know how to treat with medical care and dietary changes.

High blood pressure alone has measurable effects on the brain in MS. It's linked to greater brain atrophy over five years, enlargement of fluid-filled spaces in the brain, and more white matter damage (Jakimovski et al., 2018; Dossi et al., 2018). These aren't abstract heart-health concerns. They are physical changes in the brain itself.

Cholesterol, Diabetes, and Relapse Risk

High cholesterol is linked to a 67% higher relapse rate (Kowalec et al., 2017). Higher LDL — often called "bad cholesterol" — is associated with greater disability and more MRI lesions (Tadić et al., 2022). Type 2 diabetes is tied to faster progression toward disability milestones. And when obesity and smoking occur together, the risk appears to compound further (Tettey et al., 2016).

These findings have been replicated across multiple study groups.

Mental Health Isn't Separate From MS Outcomes

Depression isn't just a quality-of-life issue in MS. It accounts for about 18% of the differences seen in quality of life, making it one of the strongest drivers of reduced well-being in this population (Marck et al., 2016). Psychiatric conditions are also independently linked to higher disability scores, particularly in women (McKay et al., 2018). Depression and anxiety in MS aren't always just emotional responses to the diagnosis — they can be primary symptoms of the disease itself, arising from central nervous system changes. That distinction shapes treatment expectations.

Comorbidities and Life Expectancy

Mortality data rarely comes up in conversations about MS diets — but it should. MS is associated with a median reduction in life expectancy of 7–14 years compared with the general population (Marrie et al., 2015). Comorbidities — especially vascular, visual, and psychiatric conditions — add independent mortality risk on top of that (Salter et al., 2016).

Many of the cardiometabolic conditions influenced by diet are also linked to shortened survival. Managing them is part of MS care.

In 2017, MS comorbidity researcher Ruth Ann Marrie wrote:

"Our understanding of the burden and complexity of comorbidity in MS has increased substantially over the past 5 years, and will continue to increase, as it is clear now that we need to think about modifying comorbidity to improve outcomes. It is time to integrate comorbidity management into MS care."

That was 2017. The evidence has only grown since then. But mainstream MS nutrition messaging hasn't fully caught up.

Where Diet Has the Strongest Evidence in MS

If we're asking where diet has the clearest, most measurable impact for people living with MS, it's not in a diet that targets MS itself.

It's in cardiometabolic health.

The strongest overlap between nutrition science and MS outcomes shows up in the management of high blood pressure, high cholesterol and triglycerides, type 2 diabetes and insulin resistance, cardiovascular disease, and obesity. These conditions share two things: they're consistently linked to worse MS progression, and we have decades of high-quality evidence showing how to manage them with targeted nutrition strategies.

Not "eat these anti-inflammatory foods." Not a branded protocol. Structured, evidence-based Medical Nutrition Therapy with clear clinical goals and measurable outcomes. The kind of thing where you can actually check your CRP, your sed rate, your lipid panel, your HbA1c — before and after — and see if anything changed. Nobody promoting "anti-inflammatory diets for MS" is asking you to do that. Which should tell you something.

Hypertension: The DASH Connection

High blood pressure isn't just a heart issue in MS. It's linked to faster disability progression and greater brain shrinkage. The dietary approach with the strongest evidence is the DASH (Dietary Approaches to Stop Hypertension) pattern, which in clinical trials lowers systolic blood pressure by about 8–14 mmHg. In some cases, that's comparable to starting a single blood pressure medication.

Lowering blood pressure isn't only about protecting your heart. In MS, it's directly connected to long-term brain health and neurological outcomes.

Dyslipidemia: Cholesterol That's Neurologically Relevant

High cholesterol is linked to higher relapse rates, greater disability, and more MRI lesions. This isn't peripheral to MS care — it's neurologically relevant. Heart-healthy eating patterns — reducing saturated fat, increasing soluble fiber, getting adequate omega-3s, emphasizing whole plant foods — have consistently been shown to improve LDL, HDL, and triglyceride levels.

A 67% higher relapse rate is associated with high cholesterol. That number alone should make lipid management part of every MS care conversation.

Type 2 Diabetes and Insulin Resistance: Blood Sugar Isn't Metabolically Neutral

Type 2 diabetes and insulin resistance are linked to faster progression toward disability milestones. The dietary strategies with strong evidence here include attention to carbohydrate quality and distribution, increasing dietary fiber, and improving overall cardiometabolic health. These approaches consistently improve fasting glucose, HbA1c, and insulin sensitivity.

Because diabetes is associated with accelerated disability progression, managing blood sugar isn't just generally "healthy." In MS, it's directly relevant to long-term neurological outcomes.

The Real Target Is Metabolic Health

Fat tissue isn't passive storage — it's biologically active, producing inflammatory mediators, affecting insulin signaling, and influencing vascular health. These are the metabolic pathways that connect body composition to MS outcomes.

The evidence-based approach isn't crash dieting or extreme restriction. It's improving metabolic function through nutritional adequacy, higher-quality food choices, and sustainable eating patterns. When blood pressure, glucose, and lipid markers improve, MS-relevant outcomes tend to improve as well — regardless of what happens on the scale. Weight change, if it happens, is secondary.

Cardiovascular Disease: Not Optional in MS Care

People with MS have a higher risk of cardiovascular disease than the general population. The dietary patterns with the strongest evidence in all of nutrition science — [Mediterranean-style eating](best-diet-for-multiple-sclerosis), DASH-style eating, and fiber-rich cardiometabolic approaches — directly improve blood pressure, cholesterol levels, blood vessel function, and inflammatory markers. Because cardiovascular disease independently worsens MS progression and mortality risk, addressing it through diet has clear clinical relevance.

When Popular MS Diets Clash With Other Health Conditions

Here's something that doesn't get talked about often enough: some MS-focused diets may not align with evidence-based management of common comorbidities. MS rarely exists in isolation, and a plan that supports one dimension of health may complicate another.

This is where the popular MS diets — the ones covered in detail in [MS Diets Explained: Wahls, Swank, Mediterranean, and More]— deserve scrutiny not just on their MS evidence (which is limited), but on how they interact with conditions that have strong dietary evidence.

Ketogenic diet and high cholesterol. Ketogenic diets are sometimes promoted in MS communities, but they're also known to raise LDL cholesterol in some people. If someone with MS already has elevated cholesterol — which is linked to a 67% higher relapse rate — adopting a diet that may increase LDL isn't a neutral choice. A diet can't be judged on potential neurological benefits alone. In MS, cardiovascular risk is neurological risk.

Very low-fat diets and bone health. Programs like Swank and OMS recommend significant fat restriction. But dietary fat is necessary for absorbing fat-soluble vitamins, including vitamin D and vitamin K — both essential for bone health. People with MS already face a higher osteoporosis risk from corticosteroid use, reduced mobility, and vitamin D deficiency. Severely restricting fat without careful nutritional oversight raises reasonable questions about long-term bone health.

Elimination diets and blood sugar. Some MS diet plans eliminate legumes — one of the most well-supported foods in cardiometabolic nutrition. Legumes are linked to improved insulin sensitivity, better blood sugar control, lower LDL cholesterol, and higher fiber intake. For someone with MS and insulin resistance, removing legumes without a thoughtful replacement plan could make blood sugar management harder. And then there's the broader irony: many of the same protocols that eliminate fiber-rich foods also emphasize gut health. Fiber supports gut health. The math doesn't work.

Highly restrictive diets and depression. Rigid food rules can introduce social isolation, nutrient gaps, and cycles of guilt and "starting over." For someone already living with depression or anxiety in MS — and remember, depression is one of the strongest drivers of reduced quality of life — that kind of rigidity can increase stress rather than ease it. Even if the diet promises neurological benefits.

The point isn't that MS-specific diets are theoretically wrong. It's that they shouldn't be evaluated in isolation. Your nutrition plan should account for your full health picture — cardiometabolic risk, bone density, mental health, medication use, mobility, and lab markers. MS doesn't exist in isolation. Your nutrition plan shouldn't either.

A Practical Framework: What to Do With This Information

So what does this actually mean for your plate?

The takeaway is simpler than it sounds: instead of starting with a branded MS diet, start with your actual health profile. Here's how.

Step 1: Get Clear on What You're Managing

Before changing your diet, get clear on what you're targeting. MS often takes center stage, and other risk factors quietly drift out of focus.

Ask yourself — and your healthcare team:

• What's my blood pressure?

• What does my lipid panel show (LDL, HDL, triglycerides)?

• What's my fasting glucose or HbA1c?

• Do I have insulin resistance?

• Have I been screened for depression or anxiety?

• When was my last vitamin D level checked?

If these haven't been reviewed recently, that conversation may matter more for long-term MS outcomes than choosing between diet protocols. You can't choose the right strategy if you don't know the target.

Step 2: Match the Diet to the Condition

Once you know what you're managing, use the dietary approach with the strongest evidence for that condition. Hypertension? DASH-style eating. High cholesterol? Heart-healthy, fiber-rich patterns. Insulin resistance or type 2 diabetes? Structured carbohydrate management. Bone health risk? Adequate calcium, optimized vitamin D, and avoiding unnecessary restriction.

These are well-established strategies — and they align closely with eating patterns associated with better overall MS outcomes. When cardiometabolic health improves, MS-relevant markers often improve too. That's measurable. That's the problem → intervention → outcome test applied to your actual situation.

Step 3: Check Your Current Approach for Conflicts

If you're already following a specific MS diet — ketogenic, low-fat, elimination-based, or something else — pause and ask: Does this support my blood pressure? Does it improve or worsen my cholesterol? Is it helping my blood sugar? Is it sustainable for my mental health?

Sometimes the answer is yes. Sometimes adjustments are needed. This is where a registered dietitian — ideally one familiar with both MS and cardiometabolic care — can be especially helpful. Nutrition is individualized. Your health picture is bigger than MS alone.

Step 4: Don't Fix What Isn't Broken

If you're already following a balanced, sustainable eating pattern that keeps your blood pressure controlled, improves your cholesterol, supports healthy blood sugar, and feels psychologically manageable, you may already be using the most evidence-based approach available.

There's no requirement to add MS-specific restrictions if those markers are moving in the right direction.

Permission to simply eat.

To eat simply.

No obstacle course on the way to dinner.

Newly diagnosed and feeling overwhelmed by all the diet advice? See Newly Diagnosed with MS? What You Actually Need to Know About Diet.

The Better Question

The MS diet industry asks: "What should you eat for multiple sclerosis?"

It's a compelling question. But the evidence suggests a better one: What health conditions do you have that diet can measurably improve — and how are those conditions influencing your MS outcomes?

The first question often leads to branded MS protocols that promise [inflammation control or neuroprotection](anti-inflammatory-diet-ms) but lack strong evidence for meaningful disease modification in human trials.

The second leads to approaches grounded in decades of clinical nutrition research: blood pressure control with DASH-style eating, cholesterol management through heart-healthy eating patterns, blood glucose stabilization, adequate vitamin D and calcium for bone protection, and sustainable, psychologically supportive eating patterns.

These strategies target conditions consistently associated with worse MS outcomes. When hypertension, dyslipidemia, diabetes, or depression improve, MS-relevant markers often improve alongside them. That's measurable. That's the kind of evidence you can actually track with your own lab results.

Eating for cardiovascular, metabolic, bone, and mental health is eating for MS. Not a branded diet. Not an elimination protocol. Comprehensive, individualized nutrition that treats comorbidities as central to MS care — not secondary to it.

As I tell my clients, the best diet for MS probably doesn't have "MS" in its name.

Frequently Asked Questions About MS, Comorbidities, and Diet

I have MS. Should I follow an MS diet or a diet for my other health conditions?

For most people with MS who have one or more comorbid conditions, the evidence-based dietary management of those conditions is likely to have a more measurable impact on MS-relevant outcomes than any MS-specific dietary protocol. The good news is that these approaches usually overlap — a heart-healthy, metabolically supportive eating pattern is also what the limited MS diet research points toward.

Can a diet for hypertension or diabetes also be good for MS?

Yes — and in many cases, it's the strongest option available. DASH-style eating, Mediterranean-style patterns, and balanced carbohydrate management are all consistent with the general healthy eating principles associated with better MS outcomes. Managing a comorbidity through diet rarely requires anything that conflicts with MS-relevant nutrition principles — though it's worth checking if you're following a restrictive MS-specific protocol.

My neurologist hasn't mentioned my other health conditions in relation to my MS. Should they have?

The connection between comorbidities and MS outcomes is well-established in the research, but doesn't always filter into clinical conversations — particularly when the neurologist's focus is appropriately on your neurological care. This is a conversation worth initiating. Ask how your other health conditions might be affecting your MS, and whether your dietary approach is optimized for your full health picture.

Where do I start if I want to address my comorbidities through diet?

With your healthcare team, specifically a registered dietitian with experience in MS and chronic disease management. The right starting point depends on your conditions, how well they're currently managed, the medications you're taking, and your current eating pattern. General information can point you in the right direction. Personalized assessment is what translates that direction into an approach that actually works for your situation.

References

Culpepper, W. J., Marrie, R. A., Langer-Gould, A., et al. (2015). Comorbidity increases the risk of hospitalizations in MS: Prevention opportunities. Neurology, 84(4), 350–358. https://doi.org/10.1212/WNL.0000000000001194

Dagan, A., Gringouz, I., Kliers, I., et al. (2016). Disability progression in multiple sclerosis is affected by the emergence of comorbid arterial hypertension. Journal of Clinical Neurology, 12(3), 345–350. https://doi.org/10.3988/jcn.2016.12.3.345

Dossi, D. E., Chaves, H., Heck, E. S., et al. (2018). Effects of systolic blood pressure on brain integrity in multiple sclerosis. Frontiers in Neurology, 9, 487. https://doi.org/10.3389/fneur.2018.00487

Jakimovski, D., Weinstock-Guttman, B., Gandhi, S., et al. (2018). Hypertension and heart disease are independently associated with development of brain atrophy in multiple sclerosis patients: A 5-year longitudinal study. Neurology, 90(Suppl 15). https://doi.org/10.1212/WNL.90.15\_supplement.P2.345

Kowalec, K., McKay, K. A., Patten, S. B., et al. (2017). Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study. Neurology, 89(24), 2455–2461. https://doi.org/10.1212/WNL.0000000000004716

Marck, C. H., Neate, S. L., Taylor, K. L., et al. (2016). Prevalence of comorbidities, overweight, and obesity in an international sample of people with multiple sclerosis and associations with modifiable lifestyle factors. PLoS One, 11(2), e0148573. https://doi.org/10.1371/journal.pone.0148573

Maric, G., Pekmezovic, T., Mesaros, S., et al. (2021). The prevalence of comorbidities in patients with multiple sclerosis: Population-based registry data. Neurological Sciences, 42(5), 2047–2053. https://doi.org/10.1007/s10072-020-04727-5

Marrie, R. A. (2017). Comorbidity in multiple sclerosis: Implications for patient care. Nature Reviews Neurology, 13(6), 375–382. https://doi.org/10.1038/nrneurol.2017.33

Marrie, R. A., Horwitz, R., Cutter, G., et al. (2009). Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology, 72(2), 117–124. https://doi.org/10.1212/01.WNL.0000333252.78173.5F

Marrie, R. A., Reider, N., Cohen, J., et al. (2015). Effect of comorbidity on mortality in multiple sclerosis. Neurology, 85(11), 944–950. https://doi.org/10.1212/WNL.0000000000001718

McKay, K. A., Tremlett, H., Fisk, J. D., et al. (2018). Psychiatric comorbidity is associated with disability progression in multiple sclerosis. Neurology, 90(15), e1316–e1323. https://doi.org/10.1212/WNL.0000000000005302

Salter, A., Fox, R. J., Newsome, S. D., et al. (2024). Comorbidity and disease activity in multiple sclerosis. JAMA Neurology, 81(10), 1060–1068. https://doi.org/10.1001/jamaneurol.2024.2920

Salter, A., Marrie, R. A., Agashivala, N., et al. (2016). Examining the joint effect of disability, health behaviors, and comorbidity on mortality in MS. Neurology: Clinical Practice, 6(5), 397–408. https://doi.org/10.1212/CPJ.0000000000000269

Tadić, D., Pekmezović, T., Mesaroš, Š., et al. (2022). Vascular comorbidities in patients with multiple sclerosis and their impact on physical disability. Medicinski Glasnik, 19(2), 186–192. https://doi.org/10.17392/1499-22

Tettey, P., Siejka, D., Simpson, S. Jr., et al. (2016). Frequency of comorbidities and their association with clinical disability and relapse in multiple sclerosis. Neuroepidemiology, 46(2), 106–113. https://doi.org/10.1159/000442203

Thormann, A., Sørensen, P. S., Koch-Henriksen, N., et al. (2017). Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality. Neurology, 89(16), 1668–1675. https://doi.org/10.1212/WNL.0000000000004508

Zhang, T., Tremlett, H., Zhu, F., et al. (2018). Effects of physical comorbidities on disability progression in multiple sclerosis. Neurology, 90(5), e419–e427. https://doi.org/10.1212/WNL.0000000000004885

This article is for informational purposes and is not medical advice. Diet changes — especially when managing multiple health conditions — should be discussed with your healthcare team. If you don't currently work with a registered dietitian, this might be a good time to ask your neurologist or primary care provider for a referral. Your nutrition deserves the same level of clinical attention as your disease-modifying therapy.